Tempus AI News - August 20, 2026

🟢 Tempus AI is trading 10.29% up today as Moderna vaccine results strengthen Personalis deal confidence

Tempus AI is trading $67.55 (+10.29%) as investors connect positive Phase 3 results for Moderna’s personalized cancer vaccine with Personalis, which Tempus AI...

🟢 Tempus AI is trading 6.29% up today as Merck–Moderna trial success validates Personalis-linked sequencing

Tempus AI is trading 6.29% up now at $65.11 as investors continue rewarding Wednesday’s landmark Merck–Moderna cancer-vaccine trial results. - Phase 3 success...